Search this site
Embedded Files
Skip to main content
Skip to navigation
Group33
Home
Background
Objective
Experimental Design
Analysis & Results
Future Experiments
Acknowledgements
References
Group33
Home
Background
Objective
Experimental Design
Analysis & Results
Future Experiments
Acknowledgements
References
More
Home
Background
Objective
Experimental Design
Analysis & Results
Future Experiments
Acknowledgements
References
Background
Cardiovascular diseases (CVD)
Significance (in 2018, the US)
836,546 deaths -- 1 in every 3 deaths
2300 deaths / day -- 1 death / 38 sec
Total costs >$329.7 billion
Cardiac Medications
Prevent clotting in blood vessels (strokes)
Prevent heart attacks
Costly
Severe side effects
Current Drug Testing Methods & Limitations
In vivo methods
Expensive
Slow
In vitro methods
Non-representative of human conditions
In silico methods
Can’t simulate complicated mechanisms
Page Leader: Jingwen Lu
Report abuse
Report abuse